Principia Biopharma

About:

Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.

Website: http://www.principiabio.com

Top Investors: OrbiMed, Mission BioCapital, SR One, Sofinnova Investments, Morgenthaler Ventures

Description:

Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.